Clinical Trial Update: Polymorphism Interaction to Predict Bevacizumab Efficacy

View source ↗

Summary

A completed clinical trial examined polymorphism interactions to predict the efficacy of bevacizumab in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University of Pisa | Conditions: Metastatic Breast Cancer | Status: COMPLETED